Diagnosticos da AmericaBSP:DASA3 -1.42%46 Interest Coverage is 0.97 as of Mar. 2026, which is 52% above its 10-year median of 0.64. GuruFocus rates BSP:DASA3 with a GF Score™ of 46/100 and a GF Value™ of R$1.70 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 94 Medical Diagnostics & Research companies, Diagnosticos da America ranks worse than 98.94% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Diagnosticos da America's
Operating Income
for the
three
months ended in Mar. 2026 was R$295 Mil. Diagnosticos da America's Interest Expense for the
three
months ended in Mar. 2026 was R$-303 Mil.
Diagnosticos da America's interest coverage for the quarter that ended in Mar. 2026 was 0.97.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Diagnosticos da America's Interest Coverage or its related term are showing as below:
BSP:DASA3'
s Interest Coverage Range Over the Past 10 Years
Min: 0.17 Med: 0.64 Max: 2.22
Current: 0.42
BSP:DASA3's Interest Coverage is ranked worse than 98.94% of 94
companies
in the Medical Diagnostics & Research industry
Industry Median: 9.155
vs BSP:DASA3: 0.42
Diagnosticos da America (BSP:DASA3) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Diagnosticos da America Interest Coverage Related Terms
Diagnosticos da America Interest Coverage Historical Data
* Premium members only.
The historical data trend for Diagnosticos da America's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BSP:DASA3 vs TMO, DHR, IDXX: Interest Coverage Comparison
For the Diagnostics & Research subindustry, Diagnosticos da America's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnosticos da America Interest Coverage vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Diagnosticos da America's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Diagnosticos da America's Interest Coverage falls into.
Diagnosticos da America Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnosticos da America (BSP:DASA3) has a Interest Coverage of 0.97 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Diagnosticos da America and its competitors. This is 52% above median its historical median of 0.64. Over the past decade, Diagnosticos da America's Interest Coverage has ranged from 0.17 to 2.22. According to the industry distribution chart, Diagnosticos da America ranks #93 out of 94 companies in the Medical Diagnostics & Research industry, placing it in the top 98.9%.
Is Diagnosticos da America's Interest Coverage too high?
Diagnosticos da America's current Interest Coverage of 0.97 is 52% above median its 10-year median of 0.64. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 2.22. The Medical Diagnostics & Research industry median Interest Coverage is 9.16. Diagnosticos da America's value of 0.97 is 89.4% below this industry median. Based on the distribution chart, Diagnosticos da America ranks #93 out of 94 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Diagnosticos da America has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Interest Coverage compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Diagnosticos da America ranks #93 out of 94 companies for Interest Coverage. This places Diagnosticos da America in the lower half of its industry. The industry median Interest Coverage is 9.16. Diagnosticos da America's value of 0.97 is 89.4% below this benchmark. Historically, Diagnosticos da America's own Interest Coverage has ranged from 0.17 to 2.22 over the past decade. While the company's 10-year median is 0.64 vs. the industry median of 9.16, Diagnosticos da America has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Diagnostics & Research company?
The median Interest Coverage among Medical Diagnostics & Research companies is 9.16, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Diagnosticos da America's current Interest Coverage of 0.97 is 89.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Diagnosticos da America and its competitors. For the Medical Diagnostics & Research industry, the median Interest Coverage is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnosticos da America's current Interest Coverage is 0.97, which is 52% above median its own 10-year median of 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.70, compared to a current price of R$2.78 — trading 63.5% above its estimated fair value. The current Interest Coverage is 0.97, which is 52% above median its 10-year median of 0.64 and 89.4% below the Medical Diagnostics & Research industry median of 9.16. Diagnosticos da America's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Interest Coverage is 0.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued.
The current stock price of R$2.78 is trading 63.5% above its estimated GF Value™ of R$1.70.
GuruFocus considers Diagnosticos da America to be Significantly Overvalued.
Key valuation signals for BSP:DASA3:
Interest Coverage: 0.97 (52% above median its 10-year median of 0.64)
GF Value™: R$1.70 vs. price of R$2.78 (63.5% above fair value)
Industry Position: 89.4% below the Medical Diagnostics & Research median (#93 of 94)
No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
46GF Score
Get the complete analysis for BSP:DASA3
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:DASA3 has been successfully added to your 
